Life Technologies Corporation voluntarily recalled Oncomine Dx Target Test DNA Control-IVD for detection of DNA and RNA isolated from non-small cell lung cancer (NSCLC) due to an extended expiration date prior to clearance, the FDA said on March 16, 2020.
How to tell if you have it
- Brand: Life Technologies
- Product: Oncomine Dx Target Test DNA Control-IVD for detection of DNA and RNA isolated from non-small cell lung cancer (NSCLC)
- Catalog Number: A32442
- Lot Codes: S119_2174741, S119_2161574, P119_2149301, N119_2078113, S218_2069394, V118_1991153, T118_1990945, S217_2008383, S118_1988602, P118_1996941, S117_1988305
- UDI: (01)10190302006095
- UPC: 10190302006095
- Distribution: US Nationwide
The hazard
The recall involves an extended expiration date prior to clearance for the Oncomine Dx Target Test DNA Control-IVD. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Life Technologies Corporation has 6 other recalls on record since December 4, 2017. Other recent recalls of similar products include Life Technologies Torrent Suite Dx Software 5.14 Recall (February 7, 2024), Life Technologies Recalls COVID-19 Test Software (August 6, 2020), and Life Technologies CTSTM Essential 8 Medium Recall (June 11, 2019). Other recent recalls of similar products include Cook Staged Extubation Set (March 5, 2026), Cook Medical Multipurpose Drainage Catheter Recall (March 5, 2026), and GET TESTED Biological Age Test (November 3, 2025).